Insider · CIK 0001276700
Frank Karbe
Files at CDTX (Cidara Therapeutics, Inc.), PHAT (Phathom Pharmaceuticals, Inc.). First filing Dec 16, 2024, latest Dec 16, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PHAT: Phathom Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Phathom Pharmaceuticals, Inc. | $99k 12,500 shares | +28% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | AGrant or award Common Stock | +10,500 | $0.00 | $0 | 67,500 | Jun 5, 2025 |
| Jun 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,500 | $0.00 | $0 | 17,500 | Jun 5, 2025 |
| Feb 24, 2025 | CDTX Cidara Therapeutics, Inc. | AGrant or award Common Stock | +57,500 | $0.00 | $0 | 57,500 | Feb 26, 2025 |
| Feb 24, 2025 | CDTX Cidara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Feb 26, 2025 |
| Dec 13, 2024 | PHAT Phathom Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +12,500 | $7.93 | $99k | 57,000 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.